- Headquarters
- Indianapolis, United States · North America
- Value chain
- Design(Research & design); also Contract manufacturing
- What that means
- Designs products others make: fabless chip design, reference designs, architectures and IP cores.
- Founded
- 1876
- Staff
- 47,000 (2024)
- Ownership
- Listed
- Listing
- NYSE:LLY on Google Finance
- Website
- lilly.com
- Relevance
- Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Indianapolis, United StatesIn 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #15 of 50
Developed the bamlanivimab and bebtelovimab COVID-19 antibodies and is expanding into genetic medicines through its acquisitions of Verve and other gene-editing assets.
Relevance: COVID antibodies; broad therapeutics leader
Biotechnology & Health Technologies · Design · listed #23 of 50
Acquired POINT Biopharma in 2023, gaining Lu-177 radioligand candidates and a radiopharmaceutical manufacturing campus in Indianapolis.
Relevance: Lu-177 radioligand pipeline via acquisition